Downloads: 97

Files in This Item:
File Description SizeFormat 
ijms20030529.pdf733.38 kBAdobe PDFView/Open
Title: The Role of Tumor-Associated Neutrophils in Colorectal Cancer
Authors: Mizuno, Rei  kyouindb  KAKEN_id
Kawada, Kenji
Itatani, Yoshiro  kyouindb  KAKEN_id
Ogawa, Ryotaro
Kiyasu, Yoshiyuki
Sakai, Yoshiharu
Author's alias: 水野, 礼
河田, 健二
板谷, 喜朗
坂井, 義治
Keywords: neutrophils
colon cancer
tumor microenvironment
cancer immunity
Issue Date: 1-Feb-2019
Publisher: NLM (Medline)
Journal title: International journal of molecular sciences
Volume: 20
Issue: 3
Thesis number: 529
Abstract: Colorectal cancer (CRC) is one of the most common causes of cancer deaths worldwide and the number of CRC patients is increasing progressively. Despite the improvement of the surgical techniques and chemotherapy, we have not completely overcome this disease yet due to the metastases. Therefore, understanding the mechanisms through which metastasis occurs is important for overcoming CRC. Normal host cells in the tumor microenvironment, such as macrophages and fibroblasts, have been reported to promote the growth of CRCs. Although neutrophils were originally considered to have defensive functions against tumor cells, it has been revealed that some populations of neutrophils, called as tumor-associated neutrophils (TANs), have tumor-supportive functions. The plasticity between tumor-suppressive and -supportive neutrophils are regulated by transforming growth factor (TGF)-β and Interferon-β signaling. Some studies have demonstrated that TANs promote the spread of cancer cells to distant organs. TANs contribute to the tumor invasion and angiogenesis through the production of matrix metalloproteinase-9 (MMP9), vascular endothelial growth factor (VEGF), and hepatocyte growth factor (HGF) in the primary and metastatic sites. Neutrophils also promotes tumor cell dissemination by capturing circulating tumor cells using neutrophil extracellular traps and promote their migration to distant sites. The neutrophil-to-lymphocyte ratio is a well-defined predictive marker for CRC patients. In this review, we highlight the molecular signaling between TANs and CRC cells and the possibility of TANs as a potential target for cancer therapy.
Rights: © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
URI: http://hdl.handle.net/2433/236184
DOI(Published Version): 10.3390/ijms20030529
PubMed ID: 30691207
Appears in Collections:Journal Articles

Show full item record

Export to RefWorks


Export Format: 


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.